IDEXX Laboratories
(NASDAQ:IDXX)
$480.60
4.78[1.00%]
At close: May 3
$480.60
0[0.00%]
After Hours: 4:03PM EDT
Q1 2024 Earnings were released on Wed May 1st, before the market open
The most recent conference call was at 8:30 AM, 3 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
75%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
60
0100

IDEXX Laboratories Stock (NASDAQ:IDXX), Quotes and News Summary

IDEXX Laboratories Stock (NASDAQ: IDXX) stock price, news, charts, stock research, profile.

Open$485.820
Close$480.600
Volume / Avg.547.954K / 437.434K
Day Range478.450 - 493.980
52 Wk Range372.500 - 583.390
Market Cap$39.691B
P/E Ratio46.143
Dividend Yield-
ExchangeNASDAQ
RSI
40
Short Interest
2.73%
Days to Cover5.07

Recent News

Aging Pet Population Is 'Solid Longer-Term Tailwind' For IDEXX Labs: Analyst
IDEXX Laboratories reports Q1 EPS of $2.81 (up 10% Y/Y), with sales reaching $964M (7% increase). Revenue growth driven by Companion Animal Group and Water segments. Operating margin at 31.0%. 2024 revenue forecasted at $3.895-$3.965 billion.
Vandana Singh
West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak
West Pharmaceutical Services, Inc. (NYSE: WST) reported first-quarter 2024 adjusted earnings per share (ETF:EPS) of $1.56, which beat the Zacks Consensus Estimate by 20.9%. The bottom line, however, was down 21.2% year over year.
Zacks
Investor Activism: Elanco Animal Health Settles with Ancora, Adds New Board Members
Elanco Animal Health settles with Ancora, expanding board to 14 members, including Ancora's nominees Craig Wallace and Kathy Turner. Ancora's significant stake in Elanco, approximately $250 million, has driven discussions on board restructuring and CEO succession planning.
Vandana Singh
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
1
1
Jan
2
Feb
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Idexx Laboratories, Inc.
Sector
Health Care
Industry
Health Care Equipment & Supplies
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment,...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IDXX
STE

FAQ

Q

How do I buy IDEXX Laboratories (IDXX) stock?

A

You can purchase shares of IDEXX Laboratories (NASDAQ: IDXX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are IDEXX Laboratories's (IDXX) competitors?

A

Other companies in IDEXX Laboratories’s space includes: Steris (NYSE:STE), Masimo (NASDAQ:MASI), Koninklijke Philips (NYSE:PHG), Smith & Nephew (NYSE:SNN) and Abbott Laboratories (NYSE:ABT).

Q

What is the target price for IDEXX Laboratories (IDXX) stock?

A

The latest price target for IDEXX Laboratories (NASDAQ: IDXX) was reported by Barclays on Thursday, May 2, 2024. The analyst firm set a price target for 570.00 expecting IDXX to rise to within 12 months (a possible 18.60% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for IDEXX Laboratories (IDXX)?

A

The stock price for IDEXX Laboratories (NASDAQ: IDXX) is $480.6 last updated May 3, 2024 at 4:03 PM EDT.

Q

Does IDEXX Laboratories (IDXX) pay a dividend?

A

There are no upcoming dividends for IDEXX Laboratories.

Q

When is IDEXX Laboratories (NASDAQ:IDXX) reporting earnings?

A

IDEXX Laboratories’s Q2 earnings are confirmed for Tuesday, July 30, 2024.

Q

Is IDEXX Laboratories (IDXX) going to split?

A

There is no upcoming split for IDEXX Laboratories.

Q

What sector and industry does IDEXX Laboratories (IDXX) operate in?

A

IDEXX Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

People Also Watch